Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,051 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beta-Blockers and Oxidative Stress in Patients with Heart Failure.
Nakamura K, Murakami M, Miura D, Yunoki K, Enko K, Tanaka M, Saito Y, Nishii N, Miyoshi T, Yoshida M, Oe H, Toh N, Nagase S, Kohno K, Morita H, Matsubara H, Kusano KF, Ohe T, Ito H. Nakamura K, et al. Among authors: tanaka m. Pharmaceuticals (Basel). 2011 Aug 5;4(8):1088-100. doi: 10.3390/ph4081088. Pharmaceuticals (Basel). 2011. PMID: 26791643 Free PMC article. Review.
Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
Tanaka M, Nakamura K, Kusano KF, Morita H, Ohta-Ogo K, Miura D, Miura A, Nakagawa K, Tada T, Murakami M, Nishii N, Nagase S, Hata Y, Kohno K, Ouchida M, Shimizu K, Yutani C, Ohe T, Ito H. Tanaka M, et al. Cardiovasc Pathol. 2011 Jan-Feb;20(1):e37-42. doi: 10.1016/j.carpath.2010.02.002. Epub 2010 Mar 12. Cardiovasc Pathol. 2011. PMID: 20219395
Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds.
Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S, Morita H, Nishii N, Watanabe A, Tada T, Murakami M, Miyaji K, Hiramatsu S, Nakagawa K, Tanaka M, Miura A, Kimura H, Fuke S, Sumita W, Sakuragi S, Urakawa S, Iwasaki J, Ohe T. Kusano KF, et al. Among authors: tanaka m. J Am Coll Cardiol. 2008 Mar 25;51(12):1169-75. doi: 10.1016/j.jacc.2007.10.060. J Am Coll Cardiol. 2008. PMID: 18355654 Free article.
Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
Murakami M, Nakamura K, Kusano KF, Morita H, Nakagawa K, Tanaka M, Tada T, Toh N, Nishii N, Nagase S, Hata Y, Kohno K, Miura D, Ohe T, Ito H. Murakami M, et al. Among authors: tanaka m. J Cardiovasc Pharmacol. 2010 Oct;56(4):389-95. doi: 10.1097/FJC.0b013e3181f03c2f. J Cardiovasc Pharmacol. 2010. PMID: 20625312 Clinical Trial.
SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome.
Nishii N, Ogawa M, Morita H, Nakamura K, Banba K, Miura D, Kumagai N, Matsunaga A, Kawamura H, Urakawa S, Miyaji K, Nagai M, Satoh K, Nakagawa K, Tanaka M, Hiramatsu S, Tada T, Murakami M, Nagase S, Kohno K, Kusano KF, Saku K, Ohe T, Ito H. Nishii N, et al. Among authors: tanaka m. Circ J. 2010 Nov;74(12):2572-8. doi: 10.1253/circj.cj-10-0445. Epub 2010 Oct 30. Circ J. 2010. PMID: 21048329 Free article.
Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease.
Osawa K, Bessho A, Fuke S, Moriyama S, Mizobuchi A, Daido S, Tanaka M, Yumoto A, Saito H, Ito H. Osawa K, et al. Among authors: tanaka m. Heart Vessels. 2020 Nov;35(11):1483-1493. doi: 10.1007/s00380-020-01624-x. Epub 2020 May 22. Heart Vessels. 2020. PMID: 32444933
15,051 results
You have reached the last available page of results. Please see the User Guide for more information.